midodrine hydrochloride
midodrine hydrochloride is a pharmaceutical drug with 12 clinical trials. Currently 2 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
2
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Midodrine Use in Septic Shock
Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia
Treatment of Post-SCI Hypotension
The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury
Treatment of Orthostatic Hypotension in SCI
Clinical Trials (12)
Midodrine Use in Septic Shock
Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia
Treatment of Post-SCI Hypotension
The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury
Treatment of Orthostatic Hypotension in SCI
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
Midodrine Versus Albumin for Prevention of Paracentesis Induced Circulatory Disturbance
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
A Study for Patients With Neurogenic Orthostatic Hypotension
RaGuS Trial by Postoperative Patients
A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
Body Temperature in Persons With Tetraplegia When Exposed to Cold
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12